Analytica Limited (ALT) announced the receipt of 510(k) clearance from the US Food and Drug Administration to market the AutoStart Burette in the United States. The company said it made its initial sales of the AutoStart Burette in Australia in November, and is currently finalising a Distribution Agreement with Medical Australia Limited (MLA) for the distribution of the AutoStart Burette in Australia, New Zealand and the UK. The company said under their agreement with Analytica, Medical Australia would also become the manufacturer of the AutoStart Burette.